Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment
Chronic, low-grade inflammation increases the risk for atherosclerosis, cancer, and autoimmunity in diseases such as obesity and diabetes. Levels of CD4+ T helper 17 (Th17) cells, which secrete interleukin 17A (IL-17A), are increased in obesity and contribute to the inflammatory milieu; however, the...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2019-05, Vol.294 (22), p.8973-8990 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8990 |
---|---|
container_issue | 22 |
container_start_page | 8973 |
container_title | The Journal of biological chemistry |
container_volume | 294 |
creator | Machacek, Miranda Saunders, Harmony Zhang, Zhen Tan, Ee Phie Li, Jibiao Li, Tiangang Villar, Maria T. Artigues, Antonio Lydic, Todd Cork, Gentry Slawson, Chad Fields, Patrick E. |
description | Chronic, low-grade inflammation increases the risk for atherosclerosis, cancer, and autoimmunity in diseases such as obesity and diabetes. Levels of CD4+ T helper 17 (Th17) cells, which secrete interleukin 17A (IL-17A), are increased in obesity and contribute to the inflammatory milieu; however, the relationship between signaling events triggered by excess nutrient levels and IL-17A–mediated inflammation is unclear. Here, using cytokine, quantitative real-time PCR, immunoprecipitation, and ChIP assays, along with lipidomics and MS-based approaches, we show that increased levels of the nutrient-responsive, post-translational protein modification, O-GlcNAc, are present in naive CD4+ T cells from a diet-induced obesity murine model and that elevated O-GlcNAc levels increase IL-17A production. We also found that increased binding of the Th17 master transcription factor RAR-related orphan receptor γ t variant (RORγt) at the IL-17 gene promoter and enhancer, as well as significant alterations in the intracellular lipid microenvironment, elevates the production of ligands capable of increasing RORγt transcriptional activity. Importantly, the rate-limiting enzyme of fatty acid biosynthesis, acetyl-CoA carboxylase 1 (ACC1), is O-GlcNAcylated and necessary for production of these RORγt-activating ligands. Our results suggest that increased O-GlcNAcylation of cellular proteins may be a potential link between excess nutrient levels and pathological inflammation. |
doi_str_mv | 10.1074/jbc.RA119.008373 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6552434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820364152</els_id><sourcerecordid>31010828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-7df989e6cde2585206bf77ad55139948b43bbeb83ddf23ae64383a7e2cc13c793</originalsourceid><addsrcrecordid>eNp1UU1LAzEQDaLY-nH3JPkDW5NNttn1IBTxC4oFUfAWsslsm5LNlmxa6L83tSp6cC4zMO-9-XgIXVAyokTwq2WtRy8TSqsRISUT7AANaSoyVtD3QzQkJKdZlRflAJ30_ZKk4BU9RgNGScLl5RCt7xxsVASDZ9mD088TvXUq2s5j8AvlNfR4FbrM-saptlWxC1v8uqACN2uvP3H1FisXIVg_x3EB2PoYlAbn1k4F7OzKGtxaHTrwGxs634KPZ-ioUa6H8698it7u715vH7Pp7OHpdjLNNOciZsI0VVnBWBtIRxQ5GdeNEMoUBWVVxcuas7qGumTGNDlTMOasZEpArjVlWlTsFN3sdVfrugWjYbebk6tgWxW2slNW_u14u5DzbiPHRZFzxpMA2Quk_fs-QPPDpUTuLJDJAvlpgdxbkCiXv2f-EL5_ngDXewCkyzcWguy1hfRqYwPoKE1n_1f_AOIFmkg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Machacek, Miranda ; Saunders, Harmony ; Zhang, Zhen ; Tan, Ee Phie ; Li, Jibiao ; Li, Tiangang ; Villar, Maria T. ; Artigues, Antonio ; Lydic, Todd ; Cork, Gentry ; Slawson, Chad ; Fields, Patrick E.</creator><creatorcontrib>Machacek, Miranda ; Saunders, Harmony ; Zhang, Zhen ; Tan, Ee Phie ; Li, Jibiao ; Li, Tiangang ; Villar, Maria T. ; Artigues, Antonio ; Lydic, Todd ; Cork, Gentry ; Slawson, Chad ; Fields, Patrick E.</creatorcontrib><description>Chronic, low-grade inflammation increases the risk for atherosclerosis, cancer, and autoimmunity in diseases such as obesity and diabetes. Levels of CD4+ T helper 17 (Th17) cells, which secrete interleukin 17A (IL-17A), are increased in obesity and contribute to the inflammatory milieu; however, the relationship between signaling events triggered by excess nutrient levels and IL-17A–mediated inflammation is unclear. Here, using cytokine, quantitative real-time PCR, immunoprecipitation, and ChIP assays, along with lipidomics and MS-based approaches, we show that increased levels of the nutrient-responsive, post-translational protein modification, O-GlcNAc, are present in naive CD4+ T cells from a diet-induced obesity murine model and that elevated O-GlcNAc levels increase IL-17A production. We also found that increased binding of the Th17 master transcription factor RAR-related orphan receptor γ t variant (RORγt) at the IL-17 gene promoter and enhancer, as well as significant alterations in the intracellular lipid microenvironment, elevates the production of ligands capable of increasing RORγt transcriptional activity. Importantly, the rate-limiting enzyme of fatty acid biosynthesis, acetyl-CoA carboxylase 1 (ACC1), is O-GlcNAcylated and necessary for production of these RORγt-activating ligands. Our results suggest that increased O-GlcNAcylation of cellular proteins may be a potential link between excess nutrient levels and pathological inflammation.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.RA119.008373</identifier><identifier>PMID: 31010828</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>acetyl-CoA carboxylase (ACC) ; Acetyl-CoA Carboxylase - metabolism ; Acylation - drug effects ; Adult ; Aged ; Aged, 80 and over ; Animals ; CD4-Positive T-Lymphocytes - cytology ; CD4-Positive T-Lymphocytes - metabolism ; Cytokines - metabolism ; Fatty Acids - analysis ; Fatty Acids - biosynthesis ; Female ; Glycobiology and Extracellular Matrices ; Humans ; inflammation ; Interleukin-17 - genetics ; Interleukin-17 - metabolism ; lipid metabolism ; Lipidomics - methods ; Male ; Mice ; Mice, Inbred C57BL ; Middle Aged ; Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics ; Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism ; O-linked N-acetylglucosamine (O-GlcNAc) ; obesity ; Obesity - metabolism ; Obesity - pathology ; Promoter Regions, Genetic ; Protein Binding ; Pyrans - pharmacology ; RAR-related orphan receptor gamma t variant ; T helper cells ; Th17 ; Th17 Cells - cytology ; Th17 Cells - metabolism ; Thiazoles - pharmacology ; Transcriptional Activation - drug effects ; type 2 diabetes</subject><ispartof>The Journal of biological chemistry, 2019-05, Vol.294 (22), p.8973-8990</ispartof><rights>2019 © 2019 Machacek et al.</rights><rights>2019 Machacek et al.</rights><rights>2019 Machacek et al. 2019 Machacek et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-7df989e6cde2585206bf77ad55139948b43bbeb83ddf23ae64383a7e2cc13c793</citedby><cites>FETCH-LOGICAL-c447t-7df989e6cde2585206bf77ad55139948b43bbeb83ddf23ae64383a7e2cc13c793</cites><orcidid>0000-0003-3830-7406 ; 0000-0002-6886-4847</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552434/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552434/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31010828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Machacek, Miranda</creatorcontrib><creatorcontrib>Saunders, Harmony</creatorcontrib><creatorcontrib>Zhang, Zhen</creatorcontrib><creatorcontrib>Tan, Ee Phie</creatorcontrib><creatorcontrib>Li, Jibiao</creatorcontrib><creatorcontrib>Li, Tiangang</creatorcontrib><creatorcontrib>Villar, Maria T.</creatorcontrib><creatorcontrib>Artigues, Antonio</creatorcontrib><creatorcontrib>Lydic, Todd</creatorcontrib><creatorcontrib>Cork, Gentry</creatorcontrib><creatorcontrib>Slawson, Chad</creatorcontrib><creatorcontrib>Fields, Patrick E.</creatorcontrib><title>Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Chronic, low-grade inflammation increases the risk for atherosclerosis, cancer, and autoimmunity in diseases such as obesity and diabetes. Levels of CD4+ T helper 17 (Th17) cells, which secrete interleukin 17A (IL-17A), are increased in obesity and contribute to the inflammatory milieu; however, the relationship between signaling events triggered by excess nutrient levels and IL-17A–mediated inflammation is unclear. Here, using cytokine, quantitative real-time PCR, immunoprecipitation, and ChIP assays, along with lipidomics and MS-based approaches, we show that increased levels of the nutrient-responsive, post-translational protein modification, O-GlcNAc, are present in naive CD4+ T cells from a diet-induced obesity murine model and that elevated O-GlcNAc levels increase IL-17A production. We also found that increased binding of the Th17 master transcription factor RAR-related orphan receptor γ t variant (RORγt) at the IL-17 gene promoter and enhancer, as well as significant alterations in the intracellular lipid microenvironment, elevates the production of ligands capable of increasing RORγt transcriptional activity. Importantly, the rate-limiting enzyme of fatty acid biosynthesis, acetyl-CoA carboxylase 1 (ACC1), is O-GlcNAcylated and necessary for production of these RORγt-activating ligands. Our results suggest that increased O-GlcNAcylation of cellular proteins may be a potential link between excess nutrient levels and pathological inflammation.</description><subject>acetyl-CoA carboxylase (ACC)</subject><subject>Acetyl-CoA Carboxylase - metabolism</subject><subject>Acylation - drug effects</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Animals</subject><subject>CD4-Positive T-Lymphocytes - cytology</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>Cytokines - metabolism</subject><subject>Fatty Acids - analysis</subject><subject>Fatty Acids - biosynthesis</subject><subject>Female</subject><subject>Glycobiology and Extracellular Matrices</subject><subject>Humans</subject><subject>inflammation</subject><subject>Interleukin-17 - genetics</subject><subject>Interleukin-17 - metabolism</subject><subject>lipid metabolism</subject><subject>Lipidomics - methods</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Middle Aged</subject><subject>Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics</subject><subject>Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism</subject><subject>O-linked N-acetylglucosamine (O-GlcNAc)</subject><subject>obesity</subject><subject>Obesity - metabolism</subject><subject>Obesity - pathology</subject><subject>Promoter Regions, Genetic</subject><subject>Protein Binding</subject><subject>Pyrans - pharmacology</subject><subject>RAR-related orphan receptor gamma t variant</subject><subject>T helper cells</subject><subject>Th17</subject><subject>Th17 Cells - cytology</subject><subject>Th17 Cells - metabolism</subject><subject>Thiazoles - pharmacology</subject><subject>Transcriptional Activation - drug effects</subject><subject>type 2 diabetes</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UU1LAzEQDaLY-nH3JPkDW5NNttn1IBTxC4oFUfAWsslsm5LNlmxa6L83tSp6cC4zMO-9-XgIXVAyokTwq2WtRy8TSqsRISUT7AANaSoyVtD3QzQkJKdZlRflAJ30_ZKk4BU9RgNGScLl5RCt7xxsVASDZ9mD088TvXUq2s5j8AvlNfR4FbrM-saptlWxC1v8uqACN2uvP3H1FisXIVg_x3EB2PoYlAbn1k4F7OzKGtxaHTrwGxs634KPZ-ioUa6H8698it7u715vH7Pp7OHpdjLNNOciZsI0VVnBWBtIRxQ5GdeNEMoUBWVVxcuas7qGumTGNDlTMOasZEpArjVlWlTsFN3sdVfrugWjYbebk6tgWxW2slNW_u14u5DzbiPHRZFzxpMA2Quk_fs-QPPDpUTuLJDJAvlpgdxbkCiXv2f-EL5_ngDXewCkyzcWguy1hfRqYwPoKE1n_1f_AOIFmkg</recordid><startdate>20190531</startdate><enddate>20190531</enddate><creator>Machacek, Miranda</creator><creator>Saunders, Harmony</creator><creator>Zhang, Zhen</creator><creator>Tan, Ee Phie</creator><creator>Li, Jibiao</creator><creator>Li, Tiangang</creator><creator>Villar, Maria T.</creator><creator>Artigues, Antonio</creator><creator>Lydic, Todd</creator><creator>Cork, Gentry</creator><creator>Slawson, Chad</creator><creator>Fields, Patrick E.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3830-7406</orcidid><orcidid>https://orcid.org/0000-0002-6886-4847</orcidid></search><sort><creationdate>20190531</creationdate><title>Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment</title><author>Machacek, Miranda ; Saunders, Harmony ; Zhang, Zhen ; Tan, Ee Phie ; Li, Jibiao ; Li, Tiangang ; Villar, Maria T. ; Artigues, Antonio ; Lydic, Todd ; Cork, Gentry ; Slawson, Chad ; Fields, Patrick E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-7df989e6cde2585206bf77ad55139948b43bbeb83ddf23ae64383a7e2cc13c793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>acetyl-CoA carboxylase (ACC)</topic><topic>Acetyl-CoA Carboxylase - metabolism</topic><topic>Acylation - drug effects</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Animals</topic><topic>CD4-Positive T-Lymphocytes - cytology</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>Cytokines - metabolism</topic><topic>Fatty Acids - analysis</topic><topic>Fatty Acids - biosynthesis</topic><topic>Female</topic><topic>Glycobiology and Extracellular Matrices</topic><topic>Humans</topic><topic>inflammation</topic><topic>Interleukin-17 - genetics</topic><topic>Interleukin-17 - metabolism</topic><topic>lipid metabolism</topic><topic>Lipidomics - methods</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Middle Aged</topic><topic>Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics</topic><topic>Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism</topic><topic>O-linked N-acetylglucosamine (O-GlcNAc)</topic><topic>obesity</topic><topic>Obesity - metabolism</topic><topic>Obesity - pathology</topic><topic>Promoter Regions, Genetic</topic><topic>Protein Binding</topic><topic>Pyrans - pharmacology</topic><topic>RAR-related orphan receptor gamma t variant</topic><topic>T helper cells</topic><topic>Th17</topic><topic>Th17 Cells - cytology</topic><topic>Th17 Cells - metabolism</topic><topic>Thiazoles - pharmacology</topic><topic>Transcriptional Activation - drug effects</topic><topic>type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Machacek, Miranda</creatorcontrib><creatorcontrib>Saunders, Harmony</creatorcontrib><creatorcontrib>Zhang, Zhen</creatorcontrib><creatorcontrib>Tan, Ee Phie</creatorcontrib><creatorcontrib>Li, Jibiao</creatorcontrib><creatorcontrib>Li, Tiangang</creatorcontrib><creatorcontrib>Villar, Maria T.</creatorcontrib><creatorcontrib>Artigues, Antonio</creatorcontrib><creatorcontrib>Lydic, Todd</creatorcontrib><creatorcontrib>Cork, Gentry</creatorcontrib><creatorcontrib>Slawson, Chad</creatorcontrib><creatorcontrib>Fields, Patrick E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Machacek, Miranda</au><au>Saunders, Harmony</au><au>Zhang, Zhen</au><au>Tan, Ee Phie</au><au>Li, Jibiao</au><au>Li, Tiangang</au><au>Villar, Maria T.</au><au>Artigues, Antonio</au><au>Lydic, Todd</au><au>Cork, Gentry</au><au>Slawson, Chad</au><au>Fields, Patrick E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2019-05-31</date><risdate>2019</risdate><volume>294</volume><issue>22</issue><spage>8973</spage><epage>8990</epage><pages>8973-8990</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Chronic, low-grade inflammation increases the risk for atherosclerosis, cancer, and autoimmunity in diseases such as obesity and diabetes. Levels of CD4+ T helper 17 (Th17) cells, which secrete interleukin 17A (IL-17A), are increased in obesity and contribute to the inflammatory milieu; however, the relationship between signaling events triggered by excess nutrient levels and IL-17A–mediated inflammation is unclear. Here, using cytokine, quantitative real-time PCR, immunoprecipitation, and ChIP assays, along with lipidomics and MS-based approaches, we show that increased levels of the nutrient-responsive, post-translational protein modification, O-GlcNAc, are present in naive CD4+ T cells from a diet-induced obesity murine model and that elevated O-GlcNAc levels increase IL-17A production. We also found that increased binding of the Th17 master transcription factor RAR-related orphan receptor γ t variant (RORγt) at the IL-17 gene promoter and enhancer, as well as significant alterations in the intracellular lipid microenvironment, elevates the production of ligands capable of increasing RORγt transcriptional activity. Importantly, the rate-limiting enzyme of fatty acid biosynthesis, acetyl-CoA carboxylase 1 (ACC1), is O-GlcNAcylated and necessary for production of these RORγt-activating ligands. Our results suggest that increased O-GlcNAcylation of cellular proteins may be a potential link between excess nutrient levels and pathological inflammation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31010828</pmid><doi>10.1074/jbc.RA119.008373</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0003-3830-7406</orcidid><orcidid>https://orcid.org/0000-0002-6886-4847</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2019-05, Vol.294 (22), p.8973-8990 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6552434 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | acetyl-CoA carboxylase (ACC) Acetyl-CoA Carboxylase - metabolism Acylation - drug effects Adult Aged Aged, 80 and over Animals CD4-Positive T-Lymphocytes - cytology CD4-Positive T-Lymphocytes - metabolism Cytokines - metabolism Fatty Acids - analysis Fatty Acids - biosynthesis Female Glycobiology and Extracellular Matrices Humans inflammation Interleukin-17 - genetics Interleukin-17 - metabolism lipid metabolism Lipidomics - methods Male Mice Mice, Inbred C57BL Middle Aged Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism O-linked N-acetylglucosamine (O-GlcNAc) obesity Obesity - metabolism Obesity - pathology Promoter Regions, Genetic Protein Binding Pyrans - pharmacology RAR-related orphan receptor gamma t variant T helper cells Th17 Th17 Cells - cytology Th17 Cells - metabolism Thiazoles - pharmacology Transcriptional Activation - drug effects type 2 diabetes |
title | Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T09%3A02%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20O-GlcNAcylation%20enhances%20pro-inflammatory%20Th17%20function%20by%20altering%20the%20intracellular%20lipid%20microenvironment&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Machacek,%20Miranda&rft.date=2019-05-31&rft.volume=294&rft.issue=22&rft.spage=8973&rft.epage=8990&rft.pages=8973-8990&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.RA119.008373&rft_dat=%3Cpubmed_cross%3E31010828%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31010828&rft_els_id=S0021925820364152&rfr_iscdi=true |